• This record comes from PubMed

Serum amyloid A is a soluble pattern recognition receptor that drives type 2 immunity

. 2020 Jul ; 21 (7) : 756-765. [epub] 20200622

Language English Country United States Media print-electronic

Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't

Grant support
R56 AI118791 NIAID NIH HHS - United States
DC0190GP CIHR - Canada
P01 HL076383 NHLBI NIH HHS - United States
R01 AI132590 NIAID NIH HHS - United States
U19 AI070235 NIAID NIH HHS - United States
F32 DC000190 NIDCD NIH HHS - United States
R01 AI127644 NIAID NIH HHS - United States
T32 ES007141 NIEHS NIH HHS - United States
R01 AI083315 NIAID NIH HHS - United States

Links

PubMed 32572240
PubMed Central PMC9291269
DOI 10.1038/s41590-020-0698-1
PII: 10.1038/s41590-020-0698-1
Knihovny.cz E-resources

The molecular basis for the propensity of a small number of environmental proteins to provoke allergic responses is largely unknown. Herein, we report that mite group 13 allergens of the fatty acid-binding protein (FABP) family are sensed by an evolutionarily conserved acute-phase protein, serum amyloid A1 (SAA1), that promotes pulmonary type 2 immunity. Mechanistically, SAA1 interacted directly with allergenic mite FABPs (Der p 13 and Blo t 13). The interaction between mite FABPs and SAA1 activated the SAA1-binding receptor, formyl peptide receptor 2 (FPR2), which drove the epithelial release of the type-2-promoting cytokine interleukin (IL)-33 in a SAA1-dependent manner. Importantly, the SAA1-FPR2-IL-33 axis was upregulated in nasal epithelial cells from patients with chronic rhinosinusitis. These findings identify an unrecognized role for SAA1 as a soluble pattern recognition receptor for conserved FABPs found in common mite allergens that initiate type 2 immunity at mucosal surfaces.

Comment In

PubMed

See more in PubMed

Wills-Karp M, Nathan A, Page K & Karp CL New insights into innate immune mechanisms underlying allergenicity. Mucosal Immunol 3, 104–110 (2010). PubMed PMC

Corrigan CJ et al. Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses. J. Allergy Clin. Immunol 128, 116–124 (2011). PubMed

Gour N et al. Dysregulated invertebrate tropomyosin-dectin-1 interaction confers susceptibility to allergic diseases. Sci Immunol 3 (20): eaam9841 (2018). PubMed PMC

Schuijs MJ et al. Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells. Science 349, 1106–1110 (2015). PubMed

Smole U, Kratzer B & Pickl WF Soluble pattern recognition molecules: Guardians and regulators of homeostasis at airway mucosal surfaces. Eur. J. Immunol 50, 624–642 (2020). PubMed PMC

Urieli-Shoval S, Cohen P, Eisenberg S & Matzner Y Widespread expression of serum amyloid A in histologically normal human tissues. Predominant localization to the epithelium. J. Histochem. Cytochem 46, 1377–1384 (1998). PubMed

Malle E, Sodin-Semrl S & Kovacevic A Serum amyloid A: an acute-phase protein involved in tumour pathogenesis. Cell. Mol. Life Sci 66, 9–26 (2009). PubMed PMC

Cai Z et al. Human serum amyloid A protein inhibits hepatitis C virus entry into cells. J. Virol 81, 6128–6133 (2007). PubMed PMC

Shah C, Hari-Dass R & Raynes JG Serum amyloid A is an innate immune opsonin for Gram-negative bacteria. Blood 108, 1751–1757 (2006). PubMed

de Beer MC et al. Impact of serum amyloid A on high density lipoprotein composition and levels. J. Lipid Res 51, 3117–3125 (2010). PubMed PMC

Hinrichs BH et al. Serum Amyloid A1 Is an Epithelial Prorestitutive Factor. Am. J. Pathol 188, 937–949 (2018). PubMed PMC

Sun L & Ye RD Serum amyloid A1: Structure, function and gene polymorphism. Gene 583, 48–57 (2016). PubMed PMC

Cheng N, Liang Y, Du X & Ye RD Serum amyloid A promotes LPS clearance and suppresses LPS-induced inflammation and tissue injury. EMBO Rep 19 (10): e45517, (2018). PubMed PMC

Kim MH, de Beer MC, Wroblewski JM, Webb NR & de Beer FC SAA does not induce cytokine production in physiological conditions. Cytokine 61, 506–512 (2013). PubMed PMC

Lu J, Yu Y, Zhu I, Cheng Y & Sun PD Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis. Proc. Natl. Acad. Sci. U. S. A 111, 5189–5194 (2014). PubMed PMC

Wang Y et al. Serum amyloid A 2.2 refolds into a octameric oligomer that slowly converts to a more stable hexamer. Biochem. Biophys. Res. Commun 407, 725–729 (2011). PubMed PMC

Sano T et al. An IL-23R/IL-22 Circuit Regulates Epithelial Serum Amyloid A to Promote Local Effector Th17 Responses. Cell 163, 381–393 (2015). PubMed PMC

Ather JL et al. Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice. J. Immunol 187, 64–73 (2011). PubMed PMC

Buyukozturk S et al. Acute phase reactants in allergic airway disease. Tohoku J. Exp. Med 204, 209–213 (2004). PubMed

Jousilahti P et al. The association of sensitive systemic inflammation markers with bronchial asthma. Ann. Allergy. Asthma. Immunol 89, 381–385 (2002). PubMed

Ozseker F et al. Serum amyloid A (SAA) in induced sputum of asthmatics: a new look to an old marker. Int Immunopharmacol 6, 1569–1576 (2006). PubMed

Ricklefs I et al. ALX receptor ligands define a biochemical endotype for severe asthma. JCI Insight 2 (14): e93534. (2017). PubMed PMC

Lambrecht BN, Hammad H & Fahy JV The Cytokines of Asthma. Immunity 50, 975–991 (2019). PubMed

Cayrol C et al. Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33. Nat Immunol 19, 375–385 (2018). PubMed

Gold MJ et al. Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures. J. Allergy Clin. Immunol 133, 1142–1148 (2014). PubMed

Halim TY et al. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 40, 425–435 (2014). PubMed PMC

Ather JL et al. Serum Amyloid A3 is required for normal lung development and survival following influenza infection. Sci Rep 8, 16571 (2018). PubMed PMC

Pautsch A & Schulz GE High-resolution structure of the OmpA membrane domain. J. Mol. Biol 298, 273–282 (2000). PubMed

Niemi MH et al. Dimerization of lipocalin allergens. Sci Rep 5, 13841 (2015). PubMed PMC

Malle E et al. Mapping of antigenic determinants of purified, lipid-free human serum amyloid A proteins. Scand. J. Immunol 48, 557–561 (1998). PubMed

Suojalehto H et al. Level of Fatty Acid Binding Protein 5 (FABP5) Is Increased in Sputum of Allergic Asthmatics and Links to Airway Remodeling and Inflammation. PLoS One 10, e0127003 (2015). PubMed PMC

Thaumaturgo N, Vilar MM, Diogo CM, Edelenyi R & Tendler M Preliminary analysis of Sm14 in distinct fractions of Schistosoma mansoni adult worm extract. Mem. Inst. Oswaldo Cruz 96 Suppl, 79–83 (2001). PubMed

Franchini GR et al. The unusual lipid binding proteins of parasitic helminths and their potential roles in parasitism and as therapeutic targets. Prostaglandins Leukot. Essent. Fatty Acids 93, 31–36 (2015). PubMed

Derebe MG et al. Serum amyloid A is a retinol binding protein that transports retinol during bacterial infection. Elife 3, e03206 (2014). PubMed PMC

Zhou H, Chen M, Zhang G & Ye RD Suppression of Lipopolysaccharide-Induced Inflammatory Response by Fragments from Serum Amyloid A. J. Immunol 199, 1105–1112 (2017). PubMed

Rabiet MJ, Macari L, Dahlgren C & Boulay F N-formyl peptide receptor 3 (FPR3) departs from the homologous FPR2/ALX receptor with regard to the major processes governing chemoattractant receptor regulation, expression at the cell surface, and phosphorylation. J. Biol. Chem 286, 26718–26731 (2011). PubMed PMC

Cooray SN et al. Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses. Proc. Natl. Acad. Sci. U. S. A 110, 18232–18237 (2013). PubMed PMC

Snelgrove RJ et al. Alternaria-derived serine protease activity drives IL-33-mediated asthma exacerbations. J. Allergy Clin. Immunol 134, 583–592 (2014). PubMed PMC

Green BJ et al. Allergic sensitization in Canadian chronic rhinosinusitis patients. Allergy Asthma Clin Immunol 10, 15 (2014). PubMed PMC

Chu DK et al. IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization. J. Allergy Clin. Immunol 131, 187–200 (2013). PubMed

Rank MA et al. IL-33-activated dendritic cells induce an atypical TH2-type response. J. Allergy Clin. Immunol 123, 1047–1054 (2009). PubMed PMC

Besnard AG et al. IL-33-activated dendritic cells are critical for allergic airway inflammation. Eur. J. Immunol 41, 1675–1686 (2011). PubMed

Frame NM, Jayaraman S, Gantz DL & Gursky O Serum amyloid A self-assembles with phospholipids to form stable protein-rich nanoparticles with a distinct structure: A hypothetical function of SAA as a “molecular mop” in immune response. J. Struct. Biol 200, 293–302 (2017). PubMed PMC

Jayaraman S, Gantz DL, Haupt C & Gursky O Serum amyloid A forms stable oligomers that disrupt vesicles at lysosomal pH and contribute to the pathogenesis of reactive amyloidosis. Proc. Natl. Acad. Sci. U. S. A 114, E6507–E6515 (2017). PubMed PMC

Bjorkman L et al. The proinflammatory activity of recombinant serum amyloid A is not shared by the endogenous protein in the circulation. Arthritis Rheum 62, 1660–1665 (2010). PubMed

Christenson K et al. Endogenous Acute Phase Serum Amyloid A Lacks Pro-Inflammatory Activity, Contrasting the Two Recombinant Variants That Activate Human Neutrophils through Different Receptors. Front Immunol 4, 92 (2013). PubMed PMC

Puerta L, Kennedy MW, Jim nez S & Caraballo L Structural and ligand binding analysis of recombinant blo t 13 allergen from Blomia tropicalis mite, a fatty acid binding protein. Int. Arch. Allergy Immunol 119, 181–184 (1999). PubMed

Scott IC et al. Interleukin-33 is activated by allergen- and necrosis-associated proteolytic activities to regulate its alarmin activity during epithelial damage. Sci Rep 8, 3363 (2018). PubMed PMC

Ivanov II et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485–498 (2009). PubMed PMC

Caraballo L et al. Cloning and IgE binding of a recombinant allergen from the mite Blomia tropicalis, homologous with fatty acid-binding proteins. Int. Arch. Allergy Immunol 112, 341–347 (1997). PubMed

Zimmerman AW & Veerkamp JH New insights into the structure and function of fatty acid-binding proteins. Cell. Mol. Life Sci 59, 1096–1116 (2002). PubMed PMC

Miljkovic D et al. Association between group 2 innate lymphoid cells enrichment, nasal polyps and allergy in chronic rhinosinusitis. Allergy 69, 1154–1161 (2014). PubMed

Shaw JL et al. IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps. Am. J. Respir. Crit. Care Med 188, 432–439 (2013). PubMed PMC

Chen M, Zhou H, Cheng N, Qian F & Ye RD Serum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2. Immunobiology 219, 916–923 (2014). PubMed PMC

Lotvall J et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J. Allergy Clin. Immunol 127, 355–360 (2011). PubMed

Leontovyc A et al. SmSP2: A serine protease secreted by the blood fluke pathogen Schistosoma mansoni with anti-hemostatic properties. PLoS Negl Trop Dis 12, e0006446 (2018). PubMed PMC

Lajoie S et al. IL-21 receptor signalling partially mediates Th2-mediated allergic airway responses. Clin. Exp. Allergy 44, 976–985 (2014). PubMed PMC

Paris G, Pozharskaya T, Asempa T & Lane AP Damage-associated molecular patterns stimulate interleukin-33 expression in nasal polyp epithelial cells. Int Forum Allergy Rhinol 4, 15–21 (2014). PubMed PMC

Darveau ME, Jacques E, Rouabhia M, Hamid Q & Chakir J Increased T-cell survival by structural bronchial cells derived from asthmatic subjects cultured in an engineered human mucosa. J. Allergy Clin. Immunol 121, 692–699 (2008). PubMed

Goulet F et al. Morphologic and functional properties of bronchial cells isolated from normal and asthmatic subjects. Am. J. Respir. Cell Mol. Biol 15, 312–318 (1996). PubMed

Labrada M et al. Monoclonal antibodies against Blo t 13, a recombinant allergen from Blomia tropicalis. Int. Arch. Allergy Immunol 129, 212–218 (2002). PubMed

Kratzer B et al. Prevention of allergy by virus-like nanoparticles (VNP) delivering shielded versions of major allergens in a humanized murine allergy model. Allergy 74, 246–260 (2019). PubMed PMC

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...